None listed
Conditions
Brief summary
The purpose of this study is to examine the efficacy, feasibility, and acceptability of videoconferencing-delivered cognitive behaviour therapy (CBT) for Adult Attention-Deficit/Hyperactivity Disorder (ADHD) in adults. After assessment, all participants will complete 10 sessions of vCBT with a psychologist.
Interventions
Treatment consists of individually delivered internet-videoconferencing delivered CBT (vCBT; 10x weekly 50-minute sessions). The vCBT will be manualised and will cover: psychoeducation about ADHD and goal setting; organisational skills; reducing distractibility; psychoeducation on the CBT model of ADHD; cognitive restructuring to develop adaptive thinking; and relapse prevention. The vCBT treatment will be provided by a provisional psychologist or psychologist with 1-5 years of experience. Adher
Treatment consists of individually delivered internet-videoconferencing delivered CBT (vCBT; 10x weekly 50-minute sessions). The vCBT will be manualised and will cover: psychoeducation about ADHD and goal setting; organisational skills; reducing distractibility; psychoeducation on the CBT model of ADHD; cognitive restructuring to develop adaptive thinking; and relapse prevention. The vCBT treatment will be provided by a provisional psychologist or psychologist with 1-5 years of experience. Adherence to the treatment will be monitored by the clinician each week.
Sponsors
University of Technology Sydney
Study design
Allocation
Non-randomised trial
Primary purpose
Treatment
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1) Presently residing in Australia; 2) Aged 18 years or over; 3) Fluent in English; 4) Meets criteria for ADHD and the disorder is of at least “moderate severity” (defined as a score of 4 on the DIAMOND module severity measure); 5) Medication-free or on a stable dose (6 weeks) of psychotropic medication or stimulant medication; and 6) Not presently receiving regular psychological services for their ADHD-related challenges (defined as sessions at least once a week with a qualified mental health professional, including an ADHD coach); and 7) Have access to a private location to complete the treatment for the duration of the study.
Exclusion criteria
1) Suicide risk as assessed by item 9 of the Patient Health Questionnaire-9 item (PHQ-9; a score of 2 or above) at baseline, or the Colombia Suicide Severity Rating Scale (C-SSRS), or a response of ‘yes’ to item 1–3 of the risk questionnaire, or via clinician judgement during the diagnostic interview; 2) Engagement in non-suicidal self-injury in the past 12 months; 3) Daily use of alcohol or illicit drugs (meaning illegal drugs, pharmaceutical drugs used outside their prescribed or intended use, and other substances inappropriately used); 4) The presence of a schizophrenia spectrum disorder, bipolar disorder, substance use disorder, or anorexia nervosa as assessed by the DIAMOND semi-structured clinical interview; 5) Any significant cognitive/intellectual impairment as assessed during the diagnostic interview; 6) A medical condition that may interfere with treatment; 7) No access to a computer with a camera and stable internet on a regular basis; 8) Is not willing to engage in treatment on a regular basis using internet-videoconferencing software; or 9) Does not meet the threshold on the Adult ADHD Self-Report Screening Scale for DSM-5 (ASRS-5) and the WURS-25 (Wender Utah Rating Scale-25).
Outcome results
None listed